RTA 744

· Biogen

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for RTA 744, covering 2016-05-16 to 2025-05-30. Get the full timeline:

Most recent: Clinical Trial Update: A Safety Study of RTA 744 in Recurrent, Progressive or Refractory Neoplastic Meningitis [Phase 1]